Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debra H Josephs

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Journal for Immunotherapy of Cancer|October 9, 2020
Impact of age on the toxicity of immune checkpoint inhibitionAmit Samani, Shuai Zhang, Laura Spiers, et al.
Frontiers in Oncology|March 19, 2020
Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS StudySam Sollie, Aida Santaolalla, Dominique S Michaud, et al.
Clinical and Experimental Immunology|January 12, 2022
Macrophages in ovarian cancer and their interactions with monoclonal antibody therapiesGabriel Osborn, Chara Stavraka, Rebecca Adams, et al.
BMC Cancer|August 30, 2019
Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort studySam Sollie, Dominique S Michaud, Debashis Sarker, et al.
Mabs|May 28, 2025
Assessment of biophysical properties of the first-in-class anti-cancer IgE antibody drug MOv18 IgE demonstrates monomeric purity and stabilityPaul Considine, Panida Punnabhum, Callum G Davidson, et al.
Antibodies (Basel, Switzerland)|October 21, 2020
IgE Antibodies against Cancer: Efficacy and SafetyJitesh Chauhan, Alex J McCraw, Mano Nakamura, et al.
Molecular Cancer Therapeutics|November 12, 2014
Effects of BRAF mutations and BRAF inhibition on immune responses to melanomaKristina M Ilieva, Isabel Correa, Debra H Josephs, et al.
Oncoimmunology|January 30, 2018
Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs)Ricarda M Hoffmann, Ben G T Coumbe, Debra H Josephs, et al.
Cancers|September 10, 2021
Insights from IgE Immune Surveillance in Allergy and Cancer for Anti-Tumour IgE TreatmentsAlex J McCraw, Jitesh Chauhan, Heather J Bax, et al.
Mabs|November 27, 2019
<i>In vivo</i> safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat modelIwan P Williams, Silvia Crescioli, Heng Sheng Sow, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Journal for Immunotherapy of Cancer|October 9, 2020
Impact of age on the toxicity of immune checkpoint inhibitionAmit Samani, Shuai Zhang, Laura Spiers, et al.
Frontiers in Oncology|March 19, 2020
Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS StudySam Sollie, Aida Santaolalla, Dominique S Michaud, et al.
Clinical and Experimental Immunology|January 12, 2022
Macrophages in ovarian cancer and their interactions with monoclonal antibody therapiesGabriel Osborn, Chara Stavraka, Rebecca Adams, et al.
BMC Cancer|August 30, 2019
Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort studySam Sollie, Dominique S Michaud, Debashis Sarker, et al.
Mabs|May 28, 2025
Assessment of biophysical properties of the first-in-class anti-cancer IgE antibody drug MOv18 IgE demonstrates monomeric purity and stabilityPaul Considine, Panida Punnabhum, Callum G Davidson, et al.
Antibodies (Basel, Switzerland)|October 21, 2020
IgE Antibodies against Cancer: Efficacy and SafetyJitesh Chauhan, Alex J McCraw, Mano Nakamura, et al.
Molecular Cancer Therapeutics|November 12, 2014
Effects of BRAF mutations and BRAF inhibition on immune responses to melanomaKristina M Ilieva, Isabel Correa, Debra H Josephs, et al.
Oncoimmunology|January 30, 2018
Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs)Ricarda M Hoffmann, Ben G T Coumbe, Debra H Josephs, et al.
Cancers|September 10, 2021
Insights from IgE Immune Surveillance in Allergy and Cancer for Anti-Tumour IgE TreatmentsAlex J McCraw, Jitesh Chauhan, Heather J Bax, et al.
Mabs|November 27, 2019
<i>In vivo</i> safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat modelIwan P Williams, Silvia Crescioli, Heng Sheng Sow, et al.
Pageof 6